ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)

Sandström, Per; Røsok, Bard I.; Sparrelid, Ernesto; Larsen, Peter N.; Larsson, Anna L.; Lindell, Gert; Schultz, Nicolai A.; Bjørnbeth, Bjorn A.; Isaksson, Bengt; Rizell, Magnus; Björnsson, Bergthor

ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)

Mark

Sandström, Per ; Røsok, Bard I. ; Sparrelid, Ernesto ; Larsen, Peter N. ; Larsson, Anna L. ; Lindell, Gert ^LU ; Schultz, Nicolai A. ; Bjørnbeth, Bjorn A. ; Isaksson, Bengt and Rizell, Magnus , et al. (2018) In Annals of Surgery 267(5). p.833-840

Abstract: Objective: The aim of the study was to evaluate if associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) could increase resection rates (RRs) compared with two-stage hepatectomy (TSH) in a randomized controlled trial (RCT). Background: Radical liver metastasis resection offers the only chance of a cure for patients with metastatic colorectal cancer. Patients with colorectal liver metastasis (CRLM) and an insufficient future liver remnant (FLR) volume are traditionally treated with chemotherapy with portal vein embolization or ligation followed by hepatectomy (TSH). This treatment sometimes fails due to insufficient liver growth or tumor progression. Methods: A prospective, multicenter RCT was conducted... (More); Objective: The aim of the study was to evaluate if associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) could increase resection rates (RRs) compared with two-stage hepatectomy (TSH) in a randomized controlled trial (RCT). Background: Radical liver metastasis resection offers the only chance of a cure for patients with metastatic colorectal cancer. Patients with colorectal liver metastasis (CRLM) and an insufficient future liver remnant (FLR) volume are traditionally treated with chemotherapy with portal vein embolization or ligation followed by hepatectomy (TSH). This treatment sometimes fails due to insufficient liver growth or tumor progression. Methods: A prospective, multicenter RCT was conducted between June 2014 and August 2016. It included 97 patients with CRLM and a standardized FLR (sFLR) of less than 30%. Primary outcome - RRs were measured as the percentages of patients completing both stages of the treatment. Secondary outcomes were complications, radicality, and 90-day mortality measured from the final intervention. Results: Baseline characteristics, besides body mass index, did not differ between the groups. The RR was 92% [95% confidence interval (CI) 84%-100%] (44/48) in the ALPPS arm compared with 57% (95% CI 43%-72%) (28/49) in the TSH arm [rate ratio 8.25 (95% CI 2.6-26.6); P < 0.0001]. No differences in complications (Clavien-Dindo ≥3a) [43% (19/44) vs 43% (12/28)] [1.01 (95% CI 0.4-2.6); P = 0.99], 90-day mortality [8.3% (4/48) vs 6.1% (3/49)] [1.39 [95% CI 0.3-6.6]; P = 0.68] or R0 RRs [77% (34/44) vs 57% (16/28)] [2.55 [95% CI 0.9-7.1]; P = 0.11)] were observed. Of the patients in the TSH arm that failed to reach an sFLR of 30%, 12 were successfully treated with ALPPS. Conclusion: ALPPS is superior to TSH in terms of RR, with comparable surgical margins, complications, and short-term mortality.
(Less)

Please use this url to cite or link to this publication: https://lup.lub.lu.se/record/ccb687e9-6d08-41af-8425-6b62ec560293

author

Sandström, Per ; Røsok, Bard I. ; Sparrelid, Ernesto ; Larsen, Peter N. ; Larsson, Anna L. ; Lindell, Gert ^LU ; Schultz, Nicolai A. ; Bjørnbeth, Bjorn A. ; Isaksson, Bengt and Rizell, Magnus , et al. (More)

Sandström, Per ; Røsok, Bard I. ; Sparrelid, Ernesto ; Larsen, Peter N. ; Larsson, Anna L. ; Lindell, Gert ^LU ; Schultz, Nicolai A. ; Bjørnbeth, Bjorn A. ; Isaksson, Bengt ; Rizell, Magnus and Björnsson, Bergthor (Less)

organization

Hepato-Pancreato-Biliary Surgery (research group)

publishing date

2018-05-01

type

Contribution to journal

publication status

published

subject

Surgery

keywords

associating liver partition and portal vein ligation for staged hepatectomy, colorectal liver metastasis, portal embolization, portal ligation, RCT, two-stage hepatectomy

in

Annals of Surgery

volume

267

issue

5

pages

8 pages

publisher

Lippincott Williams & Wilkins

external identifiers

scopus:85038383293
pmid:28902669

ISSN

0003-4932

DOI

10.1097/SLA.0000000000002511

language

English

LU publication?

yes

id

ccb687e9-6d08-41af-8425-6b62ec560293

date added to LUP

2018-05-22 14:58:58

date last changed

2024-06-24 14:33:18

@article{ccb687e9-6d08-41af-8425-6b62ec560293,
  abstract     = {{<p>Objective: The aim of the study was to evaluate if associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) could increase resection rates (RRs) compared with two-stage hepatectomy (TSH) in a randomized controlled trial (RCT). Background: Radical liver metastasis resection offers the only chance of a cure for patients with metastatic colorectal cancer. Patients with colorectal liver metastasis (CRLM) and an insufficient future liver remnant (FLR) volume are traditionally treated with chemotherapy with portal vein embolization or ligation followed by hepatectomy (TSH). This treatment sometimes fails due to insufficient liver growth or tumor progression. Methods: A prospective, multicenter RCT was conducted between June 2014 and August 2016. It included 97 patients with CRLM and a standardized FLR (sFLR) of less than 30%. Primary outcome - RRs were measured as the percentages of patients completing both stages of the treatment. Secondary outcomes were complications, radicality, and 90-day mortality measured from the final intervention. Results: Baseline characteristics, besides body mass index, did not differ between the groups. The RR was 92% [95% confidence interval (CI) 84%-100%] (44/48) in the ALPPS arm compared with 57% (95% CI 43%-72%) (28/49) in the TSH arm [rate ratio 8.25 (95% CI 2.6-26.6); P &lt; 0.0001]. No differences in complications (Clavien-Dindo ≥3a) [43% (19/44) vs 43% (12/28)] [1.01 (95% CI 0.4-2.6); P = 0.99], 90-day mortality [8.3% (4/48) vs 6.1% (3/49)] [1.39 [95% CI 0.3-6.6]; P = 0.68] or R0 RRs [77% (34/44) vs 57% (16/28)] [2.55 [95% CI 0.9-7.1]; P = 0.11)] were observed. Of the patients in the TSH arm that failed to reach an sFLR of 30%, 12 were successfully treated with ALPPS. Conclusion: ALPPS is superior to TSH in terms of RR, with comparable surgical margins, complications, and short-term mortality.</p>}},
  author       = {{Sandström, Per and Røsok, Bard I. and Sparrelid, Ernesto and Larsen, Peter N. and Larsson, Anna L. and Lindell, Gert and Schultz, Nicolai A. and Bjørnbeth, Bjorn A. and Isaksson, Bengt and Rizell, Magnus and Björnsson, Bergthor}},
  issn         = {{0003-4932}},
  keywords     = {{associating liver partition and portal vein ligation for staged hepatectomy; colorectal liver metastasis; portal embolization; portal ligation; RCT; two-stage hepatectomy}},
  language     = {{eng}},
  month        = {{05}},
  number       = {{5}},
  pages        = {{833--840}},
  publisher    = {{Lippincott Williams & Wilkins}},
  series       = {{Annals of Surgery}},
  title        = {{ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)}},
  url          = {{http://dx.doi.org/10.1097/SLA.0000000000002511}},
  doi          = {{10.1097/SLA.0000000000002511}},
  volume       = {{267}},
  year         = {{2018}},
}

Lund University Publications

LUND UNIVERSITY LIBRARIES

ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)